4599 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
StemRIM, Inc. engages in the research and development of regeneration inducing medicine. It deals with areas of disease and pipelines, autologous cell sampling devices for medical treatment, autologous stem cell collection, stem cell gene therapy and others. The company was founded by Katsuto Tamai on October 30, 2006 and is headquartered in Ibaraki, Japan.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
4599 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company